Several approaches, such as the transcriptional inhibitor of Survivin YM155, antisense oligonucleotides, immunotherapy, and gene therapy have been designed to inhibit Survivin for cancer treatment [10, 11]. This evidence concerns the gene BIRC5 and cancer.